GlaxoSmithKline (GSK) has extended its service contract with WNS (Holdings) a provider of global Business Process Management (BPM) services
Keshav Murugesh, Group CEO, WNS, said: “We are extremely proud to renew our agreement with GSK. For more than a decade, WNS has been a trusted partner driving evidence-based decisions through high-end research and analytics services.
“Under the agreement with GSK, WNS has set up a dedicated state-of-the-art Knowledge Center, driven by a team of over 600 industry experts.
“WNS leverages its deep Pharma domain knowledge, robust analytics capabilities and proprietary frameworks to deliver actionable business insights to GSK.”
With a team of over 2,500 research and analytics professionals globally, WNS said it provides a wide range of analytics services across Big Data, marketing, digital, HR, and operations.
